The Lancet. Microbe
Authors: Walker TM, Miotto P, K?ser CU, Fowler PW, Knaggs J, Iqbal Z, Hunt M, Chindelevitch L, Farhat M, Cirillo DM, Comas I, Posey J, Omar SV, Peto TE, Suresh A, Uplekar S, Laurent S, Colman RE, Nathanson CM, Zignol M, Walker AS, CRyPTIC Consortium, Seq&Treat Consortium, Crook DW, Ismail N, Rodwell TC
Volume 42 | American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Authors: Luo J, Ostrem J, Pellini B, Imbody D, Stern Y, Solanki HS, Haura EB, Villaruz LC
More than 50 years after the discovery of RAS family proteins, which harbor the most common activating mutations in cancer, the U.S. Food and Drug Administration approved the first direct allele-specific inhibitor of mutant in lung cancer. We highlight the history of discovering RAS and decades of studies targeting -driven lung cancer. A landmark article by Shokat and colleagues in 2013 elucidated allosteric inhibition of this undruggable target and paved the way for the first-in-class direct KRAS inhibitor. Although these drugs have impressive 36%-45% objective response rates with a median duration of response of 10 months, many tumors do not respond, and diverse mechanisms of resistance have already been observed; this includes new alterations, activation of alternate RTK pathway proteins, bypass pathways, and transcriptional remodeling. These resistance mechanisms can be profiled using tissue-based and plasma-based testing and help to inform clinical trial options for patients. We conclude with a discussion of research informing ongoing clinical trials to rationally test promising treatments to thwart or overcome resistance to KRAS inhibitors and target other -altered lung cancers.
View on PubMed
Journal of Asian health
Authors: Mukherjea A, Shariff-Marco S, Yang J, Tseng W, Palaniappan L, Li J, Ivey SL, Somsouk M, Gomez SL
The Journal of Heart and Lung Transplantation
Authors: J.Q. Nguyen, Y. Teklu, S. Wu, N.A. Kolaitis, T. De Marco, S.M. Fanous
The Journal of Heart and Lung Transplantation
Authors: M.Y. Rofael, T. Henry, A.A. Perez, L. Leard, T. De Marco, K.D. Jones, J. Kukreja, N. Kolaitis
The Journal of Heart and Lung Transplantation
Authors: L.L. Seijo, P. Smith, J.R. Greenland, Y. Gao, N.A. Kolaitis, A. Venado, S.R. Hays, N. Thakur, J. Kukreja, L.E. Leard, J.A. Golden, R. Shah, M. Kleinhenz, A. Perez, B. Trinh, L. Betancourt, N. Medikonda, D. Calabrese, P. Blanc, P.P. Katz, J.P. Singer
The Journal of Heart and Lung Transplantation
Authors: N.A. Kolaitis, H. Chen, D.R. Calabrese, K. Kumar, J. Obata, C. Bach, J. Golden, M. Simon, J. Kukreja, S.R. Hays, L.E. Leard, J.P. Singer, T. De Marco
The Journal of Heart and Lung Transplantation
Authors: J. Maheshwari, A. Perez, N. Kolaitis, D. Calabrese, A. Venado Estrada, J. Golden, R.J. Shah, L. Leard, M. Kleinhenz, K. Jones, A. Urisman, J. Kukreja, B. Trinh, Y. Gesthalter, J. Singer, S. Hays
The Journal of Heart and Lung Transplantation
Authors: J. Santos, S. Hays, J.A. Golden, D. Calabrese, N.A. Kolaitis, M. Kleinhenz, S. Rupal, A. Venado, L.E. Leard, J. Kukreja, J.P. Singer, J.R. Greenland
The Journal of Heart and Lung Transplantation
Authors: P. Wang, J. Leung, A. Lam, S. Lee, D.R. Calabrese, S.R. Hays, J.A. Golden, J. Kukreja, J.P. Singer, P.J. Wolters, Q. Tang, J.R. Greenland
